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Abstract. 
 
Vasoactive effects of soluble matrix proteins 
and integrin-binding peptides on arterioles are medi-
 
ated by 
 
a
 
v
 
b
 
3
 
 and 
 
a
 
5
 
b
 
1
 
 integrins. To examine the under-
 
lying mechanisms, we measured L-type Ca
 
2
 
1
 
 channel 
current in arteriolar smooth muscle cells in response to 
integrin ligands. Whole-cell, inward Ba
 
2
 
1
 
 currents were 
inhibited after application of soluble cyclic RGD pep-
tide, vitronectin (VN), fibronectin (FN), either of two 
anti–
 
b
 
3
 
 integrin antibodies, or monovalent 
 
b
 
3
 
 antibody. 
With VN or 
 
b
 
3
 
 antibody coated onto microbeads and 
presented as an insoluble ligand, current was also inhib-
ited. In contrast, beads coated with FN or 
 
a
 
5
 
 antibody 
produced significant enhancement of current after bead 
attachment. Soluble 
 
a
 
5
 
 antibody had no effect on cur-
rent
 
 
 
but blocked the increase in current evoked by FN-
coated beads and enhanced current when applied in 
combination with an appropriate IgG. The data suggest 
that 
 
a
 
v
 
b
 
3
 
 and 
 
a
 
5
 
b
 
1 
 
integrins are differentially linked 
through intracellular signaling pathways to the L-type 
Ca
 
2
 
1
 
 channel and thereby alter control of Ca
 
2
 
1
 
 influx in 
vascular smooth muscle. This would account for the va-
soactive effects of integrin ligands on arterioles and 
 
provide a
 
 
 
potential mechanism for wound recognition 
during tissue injury.
Key words: voltage-gated Ca
 
2
 
1
 
 channel • vascular 
smooth muscle • wound repair • extracellular matrix • 
integrin-mediated signaling
 
I
 
ntegrins
 
 are heterodimeric receptors (
 
a
 
, 
 
b
 
) that me-
 
diate cell–extracellular matrix (ECM)
 
1
 
 and cell–cell
adhesion events. The cytoskeleton is mechanically
 
linked to the ECM by integrins so that cytoskeletal stiffen-
ing increases in direct proportion to applied stress (Wang
et al., 1993). Integrins can therefore serve as mecha-
nochemical transducers (Ingber, 1991). Integrins can also
function as signaling receptors that transduce biochemical
signals both into and out of cells (Clark and Brugge, 1995;
Sjaastad and Nelson, 1997). Intracellular signals known to
be linked to integrins include pH, Ca
 
2
 
1
 
, protein kinase C
activation, and protein tyrosine phosphorylation (Schwartz
et al., 1991
 
a
 
;
 
 
 
Schwartz, 1993).
Integrin signaling pathways are generally believed to be
initiated by integrin clustering through interactions with
insoluble ECM ligands (Clark and Brugge, 1995). These
signals are initiated by cell interactions with ECM-coated
substrates or with beads coated with ECM proteins or an-
tiintegrin antibodies (Miyamoto et al., 1995
 
b
 
; Plopper et
al., 1995). When soluble ECM protein or antibody is
added, minimal or no signaling is thought to occur, but if
soluble antibody is followed by a cross-linking antibody,
signaling pathways are activated (Yamada and Geiger,
1997). A widely studied recognition site on ECM proteins,
including vitronectin (VN) and fibronectin (FN) (Schwarz-
bauer, 1991), is the tripeptide Arg-Gly-Asp (RGD), which
is recognized by a common subset of integrins, including
 
a
 
v
 
b
 
3
 
, 
 
a
 
5
 
b
 
1
 
, 
 
a
 
v
 
b
 
5
 
, and 
 
a
 
IIb
 
b
 
3
 
. RGD peptides are known to
disrupt integrin-dependent cell adhesive events (Akiyama,
1996) as well as produce inhibitory effects on major cellu-
lar processes such as platelet aggregation and angiogenesis
(Weiss et al., 1997). For this reason, RGD peptides are po-
tential therapeutic agents for thrombotic diseases and can-
cer. One important, unresolved issue is whether RGD
peptides act solely by disrupting cell–ECM contacts or
whether they provide direct signals to cells by binding to
unoccupied integrins. Recent data from our laboratories
suggest that soluble RGD peptides may provide vasoac-
tive signals to cells in the vascular wall (Mogford et al.,
1996, 1997; D’Angelo et al., 1997). Thus, RGD peptides
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3
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a
 
5
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, whole-cell Ba
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1
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may be capable of directly stimulating integrin-dependent
intracellular signaling pathways.
In rat cremaster muscle arterioles, integrin-binding RGD
peptides and fragments of denatured collagen type I cause
dilation through an interaction with the 
 
a
 
v
 
b
 
3
 
 integrin on
vascular smooth muscle (Mogford et al., 1996). Dilation is
associated with a decrease in intracellular Ca
 
2
 
1
 
 concentra-
tion ([Ca
 
2
 
1
 
]
 
i
 
) (D’Angelo et al., 1997) and can be prevented
by a function-blocking antibody specific for the 
 
b
 
3
 
 integrin
(Mogford et al., 1996). In addition to these prolonged ef-
fects, RGD peptides also cause a transient, endothelium-
independent constriction of arterioles, mediated by the
 
a
 
5
 
b
 
1
 
 integrin (Mogford et al., 1997). In rat afferent arteri-
oles, RGD peptide causes a sustained constriction that is
associated with an increase in smooth muscle cell [Ca
 
2
 
1
 
]
 
i
 
(Yip and Marsh, 1997). The signaling mechanisms down-
stream from integrin-ligand binding are poorly under-
stood, particularly in vascular smooth muscle cells (SMCs).
We hypothesized that the L-type, voltage-gated calcium
channel was involved in the vasoactive responses of arteri-
oles since this channel is known to be a major pathway for
calcium entry into vascular SMCs. To test this hypothesis,
we isolated single SMCs from rat cremaster arterioles and
selectively measured whole-cell calcium current before
and after application of integrin ligands in both soluble
and insoluble form.
 
Materials and Methods
 
Cell Isolation Techniques
 
Male Sprague-Dawley rats (120–200 g) were anesthetized with intraperi-
toneal injection of pentobarbital sodium (120 mg/kg). All animal handling
procedures followed institutional guidelines. The two cremaster muscles
were excised and pinned flat for vessel dissection in a 4
 
8
 
C silastic-coated
Plexiglas chamber containing Ca
 
2
 
1
 
-free saline solution. The composition
was (in mM) 147 NaCl, 8.6 KCl, 1.17 MgSO
 
4
 
, 1.2 NaH
 
2
 
PO
 
4
 
, 5.0 
 
d
 
-glucose,
2.0 pyruvate, 0.02 EDTA, and 3 MOPS (pH adjusted to 7.4 with NaOH),
with BSA (0.1 mg/ml; Amersham Life Science, Arlington Heights, IL)
added to maintain cell integrity. Dissected segments of first- and second-
order arterioles were transferred to a tube of low-Ca
 
2
 
1
 
 saline solution
containing (in mM) 144 NaCl, 5.6 KCl, 0.1 CaCl
 
2
 
, 1.0 MgCl
 
2
 
, 0.42
Na
 
2
 
HPO
 
4
 
, 0.44 NaH
 
2
 
PO
 
4
 
, 10 Hepes, 4.17 NaHCO
 
3
 
, and 1 mg/ml BSA (pH
adjusted to 7.4 with NaOH) at room temperature for 10 min. After allow-
ing the vessels to settle to the bottom of the tube, the solution was de-
canted and replaced with low-Ca
 
2
 
1
 
 saline containing 26 U/ml papain
(Sigma Chemical Co., St. Louis, MO) and 1 mg/ml dithioerythritol (Sigma
Chemical Co.). The vessels were incubated for 30 min at 37
 
8
 
C with occa-
sional agitation, after which vessel fragments were transferred to low-
Ca
 
2
 
1
 
 saline solution containing 1.95 collagenase (FALGPA U/ml; Sigma
Chemical Co.), 1 mg/ml soybean trypsin inhibitor (Sigma Chemical Co.),
and 75 U/ml elastase (Calbiochem, La Jolla, CA) for 15 min at 37
 
8
 
C. After
further digestion, the remaining fragments were rinsed two times with
low-Ca
 
2
 
1
 
 saline solution and gently triturated using a fire-polished Pas-
teur pipette to release single cells.
 
Patch Clamp Techniques
 
Perforated, whole-cell recordings were made as described previously (Rae
and Fernandez, 1991). Micropipettes were pulled from 1.5-mm glass tub-
ing (Corning No. 8161; Warner Instruments, Hamden, CT) on a program-
mable puller and fire polished. Pipette resistances ranged from 1 to 3 M
 
V
 
.
The pipettes were dipped for 2–3 s in Cs
 
1
 
 pipette solution (high Cs
 
1
 
) con-
taining (in mM) 110 CsCl, 20 TEA chloride, 10 EGTA, 2 MgCl
 
2
 
, 10
Hepes, and 1 CaCl
 
2 
 
(pH adjusted to 7.2 with CsOH) and then backfilled
with the same solution containing 240 
 
m
 
g/ml amphotericin B. An EPC-7
amplifier (HEKA, Darmstadt-Eberstadt, Germany) was used to record
current, and hydraulic manipulators (model M0-102; Narishige, Tokyo,
Japan) were used for fine control of the micropipettes. Analog to digital
 
conversions were made using a TL-1 DMA interface (Axon Instruments,
Foster City, CA) and stored on a Pentium computer for subsequent analy-
sis. Data were sampled at 5–10 kHz and filtered at 1–2 kHz using an eight-
pole Bessel filter. Series resistance varied from 2 to 6 M
 
V
 
. Current records
were analyzed using pClamp (version 6.0.3; Axon Instruments). Currents
through the L-type calcium channel were elicited by voltage ramps (from
 
2
 
100 mV to 
 
1
 
80 mV, duration
 
 5 
 
200 ms) or by voltage steps (from 
 
2
 
80
to 
 
1
 
60 mV in 10 mV increments, duration
 
 5 
 
300 ms). All experiments
were performed at 22
 
8
 
C.
A suspension of freshly dispersed cells was plated onto a thin glass cov-
erslip in a recording chamber on the stage of an inverted microscope. The
coverslip was not usually treated, but in some experiments it was coated
with FN (120 kD, 20 
 
m
 
g/ml) before addition of cells (Schwartz, 1993). Cur-
rent recordings were made from individual cells between 30 min and 3 h
after plating. Cells harvested using the digestion procedure were elon-
gated with tapered ends in physiological saline solution (PSS), refractile
under interference contrast optics, and contractile in solutions containing
140 mM K
 
1
 
 
 
or 20 mM Ba
 
2
 
1
 
. At the beginning of each experiment, the re-
cording chamber was suffused with PSS from a gravity-fed reservoir at a
rate of 1.5 ml/min. PSS had the following composition (in mM): 136 NaCl,
5.9 KCl, 10 Hepes, 1.16 NaH
 
2
 
PO
 
4
 
, 1.2 MgCl
 
2
 
, 1.8 CaCl
 
2
 
, 18 
 
d
 
-glucose, 0.02
EGTA, and 2 pyruvate (pH adjusted to 7.4 with NaOH). To record
whole-cell current through the calcium channel, Ba
 
2
 
1
 
 (20 mM) was used
as the charge carrier in place of K
 
1
 
 and Na
 
1
 
 in the bath solution. This pro-
cedure is known to increase the size of the inward currents elicited by de-
polarization, and to minimize calcium-dependent inactivation of these
currents (Griffith et al., 1994). The Ba
 
2
 
1
 
 bath solution (20 Ba
 
2
 
1
 
) contained
(in mM) 20 BaCl
 
2
 
, 124 choline chloride, 10 Hepes, and 15 
 
d
 
-glucose (pH
adjusted to 7.4 with TEA-OH).
Both ramp and step voltage protocols elicited inward, whole-cell Ba
 
2
 
1
 
currents (I
 
Ba
 
) that peaked at 
 
1
 
30 mV (range 
 
5 
 
3.0–10.4 pA/pF); typically,
these currents were stable for more than 30 min. Since current–voltage
(I-V) relations for the ramp and step protocols were nearly identical, the
average of five voltage ramps was used to measure I
 
Ba 
 
in most experi-
ments. The activation portion of the I-V curve (from 260 to 130 mV) in-
creased smoothly to a single maximum with no secondary “hump” in its
voltage dependence, which is the pattern consistent with activation of only
a single type Ca21 channel (L-type) in this tissue (Nelson et al., 1990; Cox
et al., 1992). As noted previously (Hill et al., 1996), the entire I-V relation
was shifted about 30 mV to the right in 20 mM Ba21 solution. This behav-
ior is typical for voltage-gated calcium channels because of the fact that
the equilibrium potential for the permeable ion shifts to the right with in-
creasing extracellular ion concentration. When physiological Ca21 is used
as the charge carrier, the peak of the I-V curve occurs between 210 mV
and 0 mV, and the activation threshold occurs at approximately 250 mV,
as demonstrated in other SMC preparations (Aaronson et al., 1988).
Ligand Application
VN, FN (120 kD), lyophilized cyclic GPenGRGDSPCA (cRGD, with Pen
indicating penicillamine), and the control GRGESP peptide (RGE) were
obtained from GIBCO-BRL (Gaithersburg, MD). The anti–b3 integrin
function-blocking antibodies (F11; anti–rat monoclonal), 2C9.G2 (mono-
clonal), and the anti–a5 integrin function-blocking antibody (HMa5-1;
anti–rat monoclonal raised in Armenian hamster) were obtained from
PharMingen (San Diego, CA). Anti–rat MHC class I monoclonal anti-
body (MHC; clone R4-8B1) was obtained from Seikagaku Inc. (Tokyo,
Japan). Anti–Armenian hamster monoclonal IgG was obtained from
Sigma Chemical Co. Monovalent antibodies were made by digesting F11
(in stock solution) with papain, followed by subsequent extraction of Fc
fragments using a column of anti–mouse Fc coupled to Sephadex. The re-
sulting Fab digest displayed a prominent band at 50 kD with no evidence
of intact F11 at 150 kD.
For application to single cells, each agent was added to 20 Ba21 solution
and ejected from a picospritzer pipette (General Valve Corp., Fairfield,
NJ) positioned z50 mm away from a cell (Fig. 1 A).
Application of Protein-coated Beads
Streptavidin-coated microspheres (3.2 mm in diameter) were obtained
from Bangs Laboratories (Fishers, IN). Before each experiment, the
beads were coated with protein using a biotinylation procedure. Biotiny-
lated FN, F11, VN, HMa5-1, and MHC were prepared using a method
similar to that described previously (Hnatowich et al., 1987; Larson et al.,
1992). The molar ratio of NHS-LC-Biotin (Pierce Chemical Co., Rock-
ford, IL) to protein (10 mg/ml) was 20:1. To remove unreacted biotin, ul-Wu et al. Integrin Modulation of Ca21 Current 243
trafree-MC filters were used (Millipore Corp., Bedford, MA). Nonspecific
sites on the beads were blocked by incubation with 0.1% heat-denatured
BSA in PSS. A dilute suspension of beads in Ba21 bath solution was then
used to backfill micropipettes for application to single cells. These pipettes
were positioned 5–10 mm away from the cells and fashioned so that their
tip diameters were approximately twice the diameter of the beads; gentle
pressure from a glass syringe (,2 cm H2O) was used to eject the beads
(Fig. 1 B).
Data Analysis
Whole-cell recordings were made from cells with capacitances varying
from 4 to 16 pF. We used data only from cells in which stable gigaseals
were maintained. In most analyses, the raw current value was normalized
to cell capacitance (an index of cell size) and expressed as current density
(pA/pF). Statistical comparisons were performed with repeated-measures
analysis of variance followed by post hoc tests, or with an independent
two-tail t test, as appropriate. Averaged values are expressed as mean 6
SEM. Values of P , 0.05 were considered to be statistically significant.
Results
Effect of cRGD on IBa
The effect of soluble cRGD peptide (100 mM for 1 min) on
inward Ba21 current is shown in Fig. 2. This dose of pep-
tide was reported to produce near-maximal dilation of iso-
lated cremaster arterioles (Mogford et al., 1996). Currents
from single arteriolar myocytes were elicited every 15 s by
a depolarizing pulse to 130 mV (300-ms duration) from a
holding potential of 280 mV. The time course of the re-
sponse from a representative cell is shown on the left side
Figure 1. Methods for appli-
cation of integrin ligands to
smooth muscle cells. The im-
ages show voltage-clamped
SMCs during application of
(A) soluble integrin ligand
from a picospritzer pipette or
(B) protein-coated beads us-
ing gentle aspiration from a
pipette. In both panels, the
pipette at the top is a record-
ing pipette used to hold the
cell at 280 mV. Cells are
contracted because of the so-
lutions used. In A, the lower
pipette is connected to a pi-
cospritzer for rapid applica-
tion of solutions to the area
surrounding the cell. In B, a
red blood cell can be seen on
the chamber bottom (under-
neath, not inside, the patch
pipette). The pipette at the
bottom is a large-tip pipette
containing FN-coated beads.
Two beads become attached
to the cell (white arrow), and
two remain in the pipette.
Both panels: bath solution is
20 Ba21; patch pipette solu-
tion is high Cs1; second pi-
pette solution: 20 Ba21. Bar,
10 mm.
Figure 2. Effects of soluble cRGD on IBa. (A) Time course of
changes in IBa (measurements made at 15-s intervals) for a single
arteriolar SMC in response to application of soluble cRGD pep-
tide (100 mM). Test potential was 130 mV in each case. Individ-
ual traces at right are leak-subtracted current traces at the time
points indicated by the symbols. Cell capacitance was 12 pF. (B)
Bar graph summarizing data for effects of soluble cRGD (n 5 9),
soluble RGE (n 5 4), vehicle (n 5 4), and nifedipine (1 mM, n 5
7). For each cell, the data represent peak currents 1 min after ap-
plication, as normalized to the current at the peak of the control
I-V relationship (usually 120 or 130 mV). (C) Summary I-V
curves for Ba21 current before or 60 s after application of soluble
cRGD (100 mM). Data from nine cells. All panels: bath solution
is 20 Ba21; pipette solution is high Cs1; HP 5 280 mV. *P , 0.05
vs. control.The Journal of Cell Biology, Volume 143, 1998 244
of Fig. 2 A, and individual current traces at the indicated
time points are shown on the right side. Before peptide ap-
plication, peak current ranged from 276 pA to 277 pA.
Within 15 s after application of soluble cRGD peptide
(100 mM) from a picospritzer pipette, current was inhib-
ited (to 260 pA) and maximal inhibition (to 251 pA) was
achieved 45 s after cRGD application. Nearly complete re-
covery from inhibition (to 275 pA) was observed within
30 s after peptide washout.
The average response of nine cells to soluble RGD pep-
tide is summarized in Fig. 2 B, where the data for each cell
have been normalized to the peak Ba21 current recorded
just before peptide application. On average, 100 mM
cRGD produced 22% inhibition of IBa at 130 mV (mea-
surements taken immediately before peptide washout).
Also illustrated in the bar graph are the effects of vehicle,
RGE peptide (which does not interact with integrin recep-
tors), and nifedipine, a dihydropyridine calcium channel
blocker. Neither vehicle nor RGE peptide (80 mM; n 5 4)
had a significant effect on IBa. Nifedipine (1 mM; n 5 7)
produced nearly 100% inhibition of current at this dose,
which is consistent with the behavior of an L-type Ca21
channel. A comparison of current–voltage relationships
recorded before and during cRGD application (Fig. 2 C)
indicates that inhibition of IBa occurred across the entire
range of voltages associated with activation of the L-type
Ca21 channel. Thus, there appeared to be no significant ef-
fect of RGD peptide on the threshold or reversal potential
of the current.
Effect of Vitronectin on IBa
VN is known to interact with several integrins, including
avb3 (the VN receptor). Fig. 3 A illustrates the effect of
soluble VN on IBa. Before application, peak current in this
representative cell was stable between 286 and 287 pA.
Within 15 s after ejection of soluble VN (0.04 mM) from
the picospritzer pipette, IBa decreased to 269 pA, with a
further inhibition to 249 pA at 60 s after application. Re-
covery of current was complete within 60 s after VN wash-
out. The bar graph in Fig. 3 A summarizes results from
seven cells. On average, this concentration of soluble VN
inhibited current by 39 6 5%. Although not illustrated in
this figure, inhibition of IBa by VN was sustained during
longer periods of application (48 6 7% inhibition at 4
min).
Fig. 3 B shows the effect of VN-coated beads on IBa. The
top trace shows the time course of changes in current be-
fore (time 5 0 min) and after attachment of four beads to
a representative cell. Note that both peak and steady-state
currents were inhibited within 1 min of bead attachment,
remained inhibited for z5 min, and then gradually re-
turned toward control levels even though the beads ap-
peared to remain attached. Data from six cells are summa-
rized in the lower portion of Fig. 3 B. On average, a 20%
inhibition of IBa was observed in response to bead attach-
ment. As a control for nonspecific mechanical effects asso-
ciated with bead application, the response to uncoated
beads was also tested (open circles); no significant changes
in IBa were noted with uncoated beads (n 5 5) or with
BSA-coated beads (n 5 4).
Inhibition of IBa after attachment of VN-coated beads
was proportional to the number of beads that attached to a
given cell, a process over which we had only partial con-
trol. Regression analysis of the percent inhibition of IBa as
a function of the number of attached beads gave a correla-
tion coefficient of 0.86 (DIBa 5 20.8 pA 2 5.2 3 No. of
Figure 3. Effects of VN on IBa. (A) Graph at left shows time
course of changes in IBa for a single cell before and during appli-
cation of soluble VN (0.04 mM). Test potential was 130 mV in
each case, and measurements were made at 15-s intervals. Cell
capacitance was 15 pF. Bar graph at right shows summary data
(n 5 7) for IBa 60 s after application of soluble VN compared with
control current (just before VN application). Currents were nor-
malized to the current at the peak of the control I-V relationship.
(B) Top traces show time course of changes in IBa (note com-
pressed time scale for each trace compared with traces in Fig. 2
A) for a single cell before and after application of four VN-
coated beads (at t 5 0 min). Lower graph shows summary time
course of IBa changes in response to VN-coated beads (filled cir-
cles; 2–5 beads/cell; n 5 6) or uncoated beads (open circles; n 5
5). All values were normalized to the peak value of IBa at t 5 0
min. Both panels: bath solution is 20 Ba21; pipette solution is high
Cs1; HP 5 280 mV. *P , 0.05 vs. control.Wu et al. Integrin Modulation of Ca21 Current 245
beads). For the purpose of determining the average re-
sponses of cells to coated beads in this and subsequent
protocols, data were therefore pooled from cells to which
between two and five beads attached.
Effect of b3 Antibody on IBa
To test the hypothesis that the effects of cRGD and VN
were mediated through the avb3 receptor, a function-
blocking, monoclonal antibody to the rat b3 integrin (F11)
was applied to the cells. F11 is known to block the dilatory
effects of cRGD peptide on isolated arterioles (Mogford
et al., 1996). b3 integrins are known to associate with two
different a subunits (Hemler, 1990), but only one of those,
av, has been identified in vascular smooth muscle (Yip and
Marsh, 1997). Fig. 4 A shows the time course of changes in
IBa after application of soluble F11 (0.03 mM) to a repre-
sentative cell. In this cell, soluble F11 inhibited current
from 270 pA to 245 pA by 1 min after application. Data
from nine cells are summarized in the bar graph of Fig. 4 A
and show that this dose of soluble F11 inhibited IBa by an
average of 33 6 5%. We also tested the effect of a second
b3 integrin antibody, 2C9.G2, which is reported to block
adhesion (Schultz and Armant, 1995). After 60 s of appli-
cation, soluble 2C9.G2 (0.03 mM) inhibited IBa by 22 6
4.5% (n 5 8). In addition, we made Fab fragments of F11
to test the effect of a monovalent integrin ligand on Ca21
current. After dilution to 0.03 mM in PSS, Fab fragments
caused a 29 6 5% inhibition of IBa 1 min after application
(n 5 7). As a control for nonspecific effects of antibody, a
nonintegrin binding antibody (anti–rat MHC, 0.2 mM) was
also tested; MHC had no significant effect on current (n 5
4), as shown in the right portion of Fig. 4 A.
When F11-coated beads were applied to cells, IBa was
inhibited (Fig. 4 B, closed circles). IBa was reduced to 61%
of control at 1.5 min after F11 bead attachment. The in-
hibition lasted z5 min, after which current gradually
and spontaneously returned toward control values, even
though the beads remained attached. As a control for non-
specific effects of antibody-coated beads, we tested the re-
sponses of cells to MHC-coated beads, which had no sig-
nificant effect on IBa (Fig. 4 B, open circles).
Effect of Fibronectin on IBa
Next, we examined the effect of FN on current. FN is
known to interact with both avb3 and a5b1 receptors
present in this cell type, as well as with a number of other
integrins (Hynes, 1992). Fig. 5 A shows the time course of
changes in IBa in response to soluble FN (0.1 mM). In this
cell, soluble FN inhibited IBa from 280 pA to 256 pA
within 60 s after application. The response of seven cells to
soluble FN is summarized by the bar graph in Fig. 5 A. On
average, this concentration of soluble FN reduced IBa to
75% of control at 1 min. The inhibition was maintained for
at least 10 min, when current was still reduced to 80 6 5%
(n 5 5; data not shown).
To test the effect of insoluble FN on IBa, FN-coated
beads were applied to single cells. The top trace in Fig. 5 B
shows the response of a representative cell to attachment
of three FN-coated beads. Interestingly, FN-coated beads
had the opposite effect on current compared with VN-
coated beads or F11-coated beads. Attachment of FN-
coated beads led to an enhancement of IBa as early as 1
min after bead attachment. This enhancement peaked at 2
min (z135% of control), remained stable for 10 min, and
then declined gradually by 16 min, even though the beads
remained attached. For reference, the time course of
changes in IBa in response to BSA-coated beads (which
had no significant effect on current) is shown.
Effect of a5 Antibody on IBa
The fact that insoluble VN and insoluble FN had opposite
effects on current suggests that an integrin other than avb3
might mediate the enhancement of IBa in response to FN-
coated beads. Experiments by Mogford et al. (1997) also
suggest a role for the a5b1 receptor in vasoactive responses
of arterioles because RGD peptide-mediated dilation was
converted to constriction after blockade of b3 integrins:
Figure 4. Effects of the b3 antibody, F11, on IBa. (A) Graph at left
shows time course of changes in IBa for a single cell before and
during application of soluble F11 (0.03 mM). Test potential was
130 mV in each case, and measurements were made at 15-s inter-
vals. Cell capacitance was 15 pF. Bar graph at right shows sum-
mary data for IBa 60 s after application of soluble F11 (n 5 9) or
soluble MHC (0.2 mM; n 5 4), compared with control current.
Currents were normalized to the current at the peak of the con-
trol I-V relationship. (B) Summary time course of IBa changes in
response to F11-coated beads (filled circles; n 5 6) or MHC-
coated beads (open circles; n 5 9). All values were normalized to
the peak value of IBa at t 5 0 min. Both panels: bath solution is 20
Ba21; pipette solution is high Cs1; HP 5 280 mV. *P , 0.05 vs.
control.The Journal of Cell Biology, Volume 143, 1998 246
the steady-state portion of that constriction was mediated
by endothelin and blocked by a5 antibody, but the initial
transient constriction was an endothelium-independent re-
sponse.
To test for the involvement of the a5b1 integrin in our
preparation, we used the anti–rat a5 antibody, HMa5-1.
The a5 subunit is known to associate only with b1, making
this antibody specific for the a5b1 heterodimer (Hynes,
1992). Fig. 6 A shows the effect of applying soluble HMa5-1
to a representative cell: no significant change in IBa was
observed. The bar graph in Fig. 6 A summarizes the re-
sponse of nine cells to application of soluble HMa5-1,
which on average produced less than a 2% change in IBa.
However, when beads coated with HMa5-1 were ap-
plied to cells, a large and significant increase in IBa was
consistently observed, as summarized in Fig. 6 B (left).
Within the first minute after attachment of a5-coated
beads, IBa had increased to 158% of control. IBa peaked at
170% of control z3 min after bead application and then
progressively declined toward control; however, IBa did
not completely recover even by 17 min after a5-coated
bead attachment. Individual current recordings before and
after HMa5-1 application are shown in Fig. 6 B (right).
The two sets of tracings represent currents evoked from a
holding potential of 280 mV (top) or 240 mV (bottom)
before and after attachment of HMa5-1–coated beads. As
is evident from these recordings, the current stimulated by
HMa5-1 was completely inhibited by nifedipine (1 mM),
which is consistent with the conclusion that it flowed
through L-type calcium channels. Although there is no se-
lective blocker of T-type calcium channels, the possibility
that some current might be contributed by T-type chan-
nels is ruled out by the fact that the time course of the cur-
rent recordings evoked from the two different holding po-
tentials are virtually identical.
Fig. 6 C compares the current–voltage relationships for
control current and current stimulated by bound HMa5-1.
There appeared to be no significant effect on either the
threshold or reversal potential of the current.
Effect of Antibody Pretreatment on IBa Response to 
Coated Beads
To test the idea that clustering of receptors was required
to initiate signaling through the a5b1 integrin, soluble a5
antibody was first applied to cells, and then anti–hamster
IgG was subsequently added. As shown in Fig. 7 A, there
was no response to either agent alone, but when both
agents were applied in combination, a significant enhance-
ment in current was noted. The time course of this en-
hancement was approximately the same as that seen in re-
sponse to insoluble a5 antibody (compare to Fig. 6 B).
If the response of arteriolar smooth muscle cells to FN-
coated beads involves interaction of insoluble FN with
both avb3 and a5b1 integrins, we predicted that pretreat-
ment with antibody specific to one integrin would result in
changes in current characteristic of selective activation of
the other integrin. To test this hypothesis, cells were
treated with either F11 to block b3 or HMa5-1 to block a5
before application of FN-coated beads. Fig. 7, B–D, shows
the results of these experiments.
In Fig. 7 B, application of soluble F11 caused a 30% in-
hibition of IBa, an effect which is comparable to that ob-
served previously (compare to Fig. 4 A). From this new
baseline, application of FN-coated beads increased current
from 70% of control to 116% of control. Although inter-
pretation of this response is complicated by the shift in
Figure 5. Effects of FN on IBa. (A) Graph at left shows time
course of changes in IBa for a single cell before and during appli-
cation of soluble FN (0.1 mM). Test potential was 130 mV in
each case, and measurements were made at 15-s intervals. Cell
capacitance was 12 pF. Bar graph at right shows summary data
(n 5 7 cells) for IBa 60 s after application of soluble FN, compared
with control current (just before FN application). Currents were
normalized to the current at the peak of the control I-V relation-
ship. (B) Top traces show time course of changes in IBa for a sin-
gle cell before and after application of three FN-coated beads (at
t  5  0 min). Lower graph shows summary time course of IBa
changes in response to FN-coated beads (filled circles; n 5 9) or
BSA-coated beads (open circles; n 5 4). All values were normal-
ized to the peak value of IBa at t 5 0 min. Both panels: bath solu-
tion is 20 Ba21; pipette solution is high Cs1; HP 5 280 mV. *P ,
0.05 vs. control.Wu et al. Integrin Modulation of Ca21 Current 247
baseline, the absolute change in IBa appeared to be larger
than that observed in response to FN-coated beads alone
(average increase 5 35%; Fig. 5 B) and nearly as large as
that produced by insoluble HMa5-1 (Fig. 6 B).
In Fig. 7 C, application of soluble HMa5-1 again pro-
duced no change in IBa, but subsequent application of FN-
coated beads caused a significant inhibition of current,
which is the opposite response observed to FN-coated
beads alone (Fig. 5). This observation is consistent with
the hypothesis that insoluble FN activates both b3 and a5
integrins in these cells. Importantly, it also indicates that
soluble HMa5-1 was indeed interacting with the a5b1 re-
ceptor even though no change in IBa was noted in response
to soluble HMa5-1 alone. Interestingly, simultaneous ap-
plication of F11 and HMa5-1 resulted in a 34 6 8% de-
crease in current (n 5 5), and little change in current was
noted after subsequent application of FN-coated beads
(Fig. 7 D).
Discussion
To investigate the mechanisms underlying the vasoactive
effects of ECM proteins and integrin-specific peptides on
rat skeletal muscle arterioles (Mogford et al., 1996, 1997),
we measured the response of L-type Ca21 channel current
in arteriolar myocytes to integrin ligands. Soluble avb3
ligands (cRGD, VN, FN, bivalent or monovalent b3 anti-
bodies) caused significant inhibition of calcium current, as
did beads coated with VN or b3 antibody. In contrast,
beads coated with a5b1 ligands (FN or a5 antibody) caused
significant enhancement of current. Soluble a5 antibody
alone had no effect on current but blocked the increase in
current evoked by FN-coated beads and enhanced current
when applied in combination with an appropriate IgG.
This is the first electrophysiological evidence for regula-
tion of a Ca21 channel by integrin–ligand interactions and
demonstrates that avb3 and a5b1 integrins in smooth mus-
cle are differentially linked through intracellular signaling
pathways to the L-type calcium channel.
The implications of our findings are threefold: (a) part
of the resting current through L-type Ca21 channels in vas-
cular smooth muscle, and therefore blood vessel tone, is
dependent on integrin-matrix interactions; (b) bidirec-
tional regulation of Ca21 influx in this cell type can be
achieved through preferential ligation of avb3 or a5b1 inte-
grins; (c) soluble integrin ligands can initiate signaling
through the avb3 receptor. Since ECM protein denatur-
ation and fragmentation can provide soluble integrin-spe-
cific signals to cells (Davis, 1992), this mechanism is likely
to be important in the microvascular response to injury
(Mogford et al., 1996). Inhibition of smooth muscle cell
Ca21 current could account for integrin-mediated vasodi-
lation of arterioles (Mogford et al., 1996).
Figure 6. Effects of the a5 antibody, HMa5-1, on IBa. (A) Left
trace shows time course of changes in IBa for a single cell before
and during application of soluble HMa5-1 (0.06 mM). Test poten-
tial was 130 mV in each case, and measurements were made at
15-s intervals. Cell capacitance was 8 pF. Bar graph at right shows
summary data for IBa 60 s after application of soluble HMa5-1
(n 5 9), compared with control current. Currents were normal-
ized to the current at the peak of the control I-V relationship. (B)
Left graph shows time course of average IBa changes in response
to HMa5-1–coated beads (n 5 5). HMa5-1–coated beads caused
a biphasic change in IBa with a large, significant increase lasting
about 4 min, followed by a slow return toward control while the
beads remained attached. All values were normalized to the peak
value of IBa at t 5 0 min. Right traces show current traces evoked
by a depolarizing pulse to 130 mV from a holding potential of
280 mV (top) or 240 mV (bottom). C, control; a5, HMa5-1-coated
beads attached; N, HMa5-1–coated beads attached in the pres-
ence of nifedipine (1 mM). (C) I-V curve for currents before (con-
trol) or 4 min after attachment of HMa5-1–coated beads. All
panels: bath solution is 20 Ba21; pipette solution is high Cs1; *P ,
0.05 vs. control.The Journal of Cell Biology, Volume 143, 1998 248
Integrin Signaling in Response to Tissue Injury
Local vasodilation is one of the initial responses to tissue
injury, resulting in an increase in blood flow to the affected
area. This response is mediated primarily by arterioles,
which are the strategic control point for local regulation of
pressure and flow in every tissue. Increased flow contrib-
utes to injury repair by enhancing delivery of inflamma-
tory cells to the injured site. Classic mediators of injury-
induced arteriolar dilation include reactive oxygen species
(Wei et al., 1981), tachykinins, and histamine (Treede et
al., 1990). Recently, Mogford et al. (1996) described an ad-
ditional mechanism by which RGD-containing peptides
induce vasodilation by interacting with the avb3 integrin
on smooth muscle cells of rat skeletal muscle arterioles.
Involvement of the avb3 integrin was implicated by the
findings that (a) cRGD and GRGDSP peptide were more
potent vasodilators than GRGDNP peptide (enhance-
ment of RGD potency by cyclization implicates the in-
volvement of av integrins [Pierschbacher and Ruoslahti,
1987]) and (b) dilations were attenuated in the presence of
a function-blocking b3 monoclonal antibody (Mogford et
al., 1996). In addition to synthetic peptides, fragments of
denatured collagen type I were potent vasodilators of arte-
rioles (Mogford et al., 1996). While RGD sequences are
not exposed in native collagen, cryptic RGD sites become
exposed after collagen denaturation and proteolysis, al-
lowing for their interaction with RGD-binding integrins.
Exposure of cryptic RGD sites has been proposed to be a
potential wound recognition signal during tissue injury
(Davis, 1992). Thus, a certain proportion of the avb3 re-
ceptors may normally be unoccupied on vascular smooth
muscle, and after tissue injury, generation of RGD peptide
signals that bind the receptor result in decreased Ca21 cur-
rent, arteriolar dilation, and increased blood flow to the
injured tissue.
Arteriolar dilations to RGD-containing peptides and
proteins are mediated by direct effects on vascular smooth
muscle integrins rather than on endothelial cell integrins
(Mogford et al., 1996). However, none of the downstream
signaling mechanisms in smooth muscle have been identi-
fied, except that dilation to soluble cyclo-RGD peptide is
preceded by a significant decrease in smooth muscle
[Ca21]i (D’Angelo et al., 1997). Our finding that cRGD
caused an inhibition of current through the L-type Ca21
channel in the same cell type (Fig. 2) is consistent with
data from intact vessels. In isolated arterioles (Mogford et
al., 1996; D’Angelo et al., 1997), dilation was the result of
inhibition of myogenic tone, which in resistance vessels
Figure 7. Effects of antibody
pretreatment on response to
coated beads. (A) Enhance-
ment in current (n 5 5) is ob-
served during application of
soluble HMa5-1 in combina-
tion with anti–Armenian
hamster IgG. Neither IgG or
soluble HMa5-1 alone al-
tered current, but when both
were added in combination,
current was enhanced over
approximately the same
time course as with bound
HMa5-1. (B) Time course of
change in IBa when FN-
coated beads were applied to
cells in the presence of solu-
ble F11 (0.03 mM; n 5 7).
Currents are normalized to
the value of IBa at t 5 0 min.
Soluble F11 failed to inhibit
the enhancement in IBa after
bead attachment, although it
inhibited current alone, as in
Fig. 4 A. In fact, the magni-
tude of the change in current
after FN bead attachment
was greater than in the ab-
sence of F11 (Fig. 5 B) and
similar to that observed in re-
sponse to HMa5-1–coated
beads (Fig. 6 B). (C) Time course of change in IBa when FN-coated beads were applied to cells after application of soluble HMa5-1 (0.06
mM; n 5 12). Soluble HMa5-1 alone had no effect on current but blocked the rise in current after FN bead attachment; in fact, a slight
but significant decrease in current was observed. (D) Time course of change in IBa when FN-coated beads were applied to cells after pre-
treatment with soluble HMa5-1 (0.06 mM) and soluble F11 (0.03 mM) in combination. An initial decrease in current was observed (pre-
sumably due to the effect of F11), and very little change in current was seen after application of insoluble FN. All panels: bath solution
is 20 Ba21; pipette solution is high Cs1; HP 5 280 mV. *P , 0.05 vs. control.Wu et al. Integrin Modulation of Ca21 Current 249
(Nelson et al., 1990; Hill and Meininger, 1994) is depen-
dent on basal influx of Ca21 through L-type Ca21 channels
and can be antagonized by dihydropyridines (Hill and
Meininger, 1994). We confirmed that the dihydropyridine
nifedipine completely blocked current in our cells (Figs. 2
B and 6 B). Mogford et al. (1996) found that cRGD pep-
tide also inhibited phenylephrine- and KCl-induced vascu-
lar tone, but the primary actions of both agents are known
to be mediated by Ca21 influx through voltage-gated Ca21
channels as well (Nelson et al., 1988).
Integrin-mediated [Ca21]i Signaling
Integrin-mediated [Ca21]i signaling has been demon-
strated in a number of cell types, including endothelium
(Schwartz and Denninghoff, 1994) and vascular smooth
muscle (McNamee et al., 1993). Integrins including aIIbb3,
avb6, avb5, a5b1, and avb3 (Hynes, 1992) are known to be
involved in [Ca21]i signaling responses; these integrins also
recognize the RGD sequence common to many ECM (FN,
osteopontin, and collagens) and plasma proteins (FN, VN,
and fibrinogen). Thus, our finding that Ca21 channel cur-
rent (and by direct extension Ca21 influx [Ganitkevich and
Isenberg, 1991]) is modulated after avb3 and a5b1 receptor
ligation is consistent with previous reports in the litera-
ture.
Changes in [Ca21]i initiated by integrin ligation involve a
number of mechanisms that result in Ca21 release from in-
tracellular stores and/or Ca21 influx (McNamee et al.,
1993; Somogyi et al., 1994; Sjaastad et al., 1996). In endo-
thelial cells, av integrins mediate a rise in [Ca21]i after ad-
hesion to FN (Schwartz and Denninghoff, 1994). The
mechanism underlying this response was not determined,
but [Ca21]i increases did not occur in the absence of extra-
cellular Ca21. Likewise, both Ca21 release and Ca21 influx
contributed to the [Ca21]i rise after adhesion of MDCK
cells to RGD-coated beads (Sjaastad et al., 1996), but the
influx component was more important for feedback regu-
lation of integrin-mediated adhesion. No mechanism for
integrin-mediated Ca21 influx in nonexcitable cells has
been identified, although a role for a 50-kD integrin-asso-
ciated protein, not yet characterized electrophysiologi-
cally, has been postulated (Brown, 1993; Schwartz et al.,
1993).
Our data represent the first electrophysiological evi-
dence that integrin ligation can modulate a plasma mem-
brane Ca21 channel. To make these measurements, Ba21
was used instead of Ca21 to carry current through the
L-type Ca21 channel because (a) Ba21 is more permeable
than Ca21 through this channel, resulting in larger current;
(b) Ba21 blocks the large, outward K1 current that nor-
mally masks Ca21 current in these cells; and (c) Ba21 cur-
rents do not exhibit the rapid inactivation observed when
Ca21 is used (Griffith et al., 1994). Nifedipine, a dihydro-
pyridine that is a selective antagonist of L-type calcium
channels (as opposed to other types of voltage-gated cal-
cium channels [Birnbaumer et al., 1994]) at concentrations
less than 1025 M, produced essentially a complete block
of basal Ca21 current (Fig. 2 B) as well as inhibited the
enhanced current in response to insoluble a5-antibody
(Fig. 6 B).
Although we have not directly measured [Ca21]i in our
preparation, it is highly likely that any treatment causing a
significant change in IBa would lead to a similar directional
change in [Ca21]i; this relationship has been clearly dem-
onstrated for visceral (Ganitkevich and Isenberg, 1991)
and vascular (Fleischmann et al., 1994) smooth muscle.
The previously reported decrease in arteriolar smooth
muscle [Ca21]i in response to soluble RGD peptide (D’An-
gelo et al., 1997) is consistent with inhibition of IBa by solu-
ble RGD peptide (Fig. 2). In another vascular bed, RGD
peptide caused a constriction that was associated with an
increase in SMC [Ca21]i (Yip and Marsh, 1997).
The direct effect of cRGD, VN, FN, and F11 on Ca21
channel current in isolated SMCs provides strong support
for the concept that interaction of avb3 with soluble
ligands transduces an intracellular signal in this cell type. It
remains to be determined if avb3 expressed in other cell
types, such as endothelium, delivers a similar or different
signal. However, endothelial cells (with one exception
[Bossu et al., 1989]) lack voltage-gated calcium channels
and, in some ways, use opposite mechanisms of controlling
calcium entry than smooth muscle. Therefore, it is not sur-
prising that ligation of b3 integrins might lead to increases
in endothelial cell [Ca21]i (Schwartz and Denninghoff,
1994) but opposite changes in SMC [Ca21]i.
Effects of Soluble and Insoluble Integrin Ligands on 
Ba21 Current
A number of possible explanations may account for the
differences between the effects of soluble and insoluble in-
tegrin ligands on Ca21 channel current. An obvious possi-
bility is that inhibition of current by soluble FN may be
mediated by competitive antagonism of existing integrin–
matrix interactions, as suggested for other systems (Poole
and Watson, 1995). This would require constitutive phos-
phorylation of the channel through an integrin-dependent
pathway. Indeed, the L-type calcium channel in vascular
smooth muscle has been shown to require tyrosine phos-
phorylation for normal function (Wijetunge et al., 1992;
Wijetunge and Hughes, 1996), but whether integrins regu-
late this pathway is not known. If they do, then disruption
of existing integrin–matrix interactions by soluble ligands
would produce inhibition of current while clustering of re-
ceptors by insoluble ligands (Altieri et al., 1990; Schwartz,
1993), including antibodies (Miyamoto et al., 1995a),
would produce enhancement of current. In our system,
soluble ligands of the avb3 receptor did produce inhibition
of current; however, insoluble b3 ligands (VN and F11)
also produced inhibition of current (Figs. 3 and 4). Thus, it
seems likely that these effects resulted from activation of a
signaling pathway rather than competition for existing b3–
matrix interactions. Likewise, since insoluble a5 caused en-
hancement of current, the competition hypothesis would
predict that soluble a5 should reduce current, which it
did not.
A more tenable explanation for our results is the possi-
bility that avb3 and a5b1 integrins provide distinct and op-
posing signals to regulate calcium current. As illustrated in
Fig. 8 A, we propose that selective ligands of the avb3 re-
ceptor (F11, 2C9.G2, VN) cause inhibition of current, se-
lective ligands of the a5b1 receptor (HMa5-1) cause en-
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cause an intermediate response. Our hypothesis requires
that several conditions be met: (a) b1 and b3 integrins must
signal through different mechanisms in smooth muscle
cells. This is supported by the different responses of cur-
rent to selective ligands of the two respective integrins
(Fig. 4 B vs. Fig. 6 B). In endothelial cells as well (Leaves-
ley et al., 1993), b1 and b3 integrins play different roles in
regulating Ca21 entry (Leavesley et al., 1993). Our hypoth-
esis also requires that (b) the a5b1 integrin can only be ac-
tivated by insoluble ligands. This is consistent with the ob-
servation that soluble a5 antibody had no effect on current
(Fig. 6 A), yet was an effective blocker of the response to
insoluble FN (Fig. 7 C). Experiments by other groups have
also shown that soluble a5 antibody failed to increase pHi
unless it was cross-linked with a secondary antibody to in-
duce integrin clustering (Schwartz et al., 1991b). Our hy-
pothesis requires that (c) the avb3 integrin must be capable
of signaling when ligands are supplied in either a soluble
or insoluble form. In support of this is the observation that
six different soluble b3 ligands (cRGD, VN, FN, bivalent
F11, monovalent F11, and 2C9.G2 antibody) all caused in-
hibition of IBa, as did two different insoluble b3 ligands
(VN and F11). According to our hypothesis, (d) soluble
signals must be transmitted only through the avb3 integrin
and not the a5b1 integrin. This is supported by the obser-
vation that soluble FN (a proposed ligand only for avb3)
inhibited current, while insoluble FN (a known ligand for
both avb3 and a5b1) enhanced current. Finally, our hy-
pothesis predicts that (e) selective ligands of the a5b1 re-
ceptor should produce a larger enhancement in current
than a common ligand for both integrins (Fig. 8 B). Ac-
cordingly, the magnitude of the increased current was
nearly twofold greater when cells were presented with a5
antibody–coated beads compared with FN-coated beads
(compare Figs. 5 and 6). Collectively, our data are consis-
tent with the hypothesis that avb3 ligation leads to inhibi-
tion of the Ca21 channel, whereas a5b1 ligation leads to
stimulation of the Ca21 channel. Further work will be
needed to thoroughly test this hypothesis and to deter-
mine if other integrins in vascular smooth muscle are also
linked to this channel.
Mechanisms of Calcium Current Modulation
The mechanisms by which avb3 and a5b1 ligands modulate
this calcium channel are not yet clear, but the possibility
that the ligands exert a direct effect on the channel seems
unlikely for several reasons: (a) selective antibodies for b3
and a5 integrins modulate Ca21 current, suggesting that
regulation occurs in a signaling pathway upstream from
the channel rather than at the channel itself; (b) there is no
reported RGD binding sequence in the structure of a1c,
the L-type subunit found in vascular smooth muscle (Koch
et al., 1990); and (c) antagonists such as dihydropyridines
inhibit Ca21 channels within seconds, and divalent cations
block within a fraction of a second (Dolphin, 1995;
Hughes, 1995), while inhibition of current by soluble avb3
ligands (Figs. 2–5) required z60 s to achieve .90% of its
maximal effect.
In terms of mechanisms, a more likely possibility is that
modulation of current after integrin ligation involves clus-
tering of integrin receptors, recruitment of cytoskeletal
proteins, and tyrosine phosphorylation of cytoplasmic sig-
naling molecules, such as FAK, Src, or paxillin, as they are
brought into close proximity (Clark and Brugge, 1995).
One difference between the effects of soluble and insolu-
ble ligands in our experiments is that soluble ligands had
sustained effects on current (soluble FN inhibited current
for at least 10 min), while insoluble ligands elicited
changes in current that lasted between 6 and 14 min fol-
lowed by spontaneous recovery. The latter observation
would be consistent with a phosphorylation-dependent
signaling step that is subject to negative feedback control.
This could occur at the level of the receptor, at the chan-
nel, or at an intermediate step. In this regard, the affinity
of the a5b1 integrin for ligand has been shown to be con-
trolled by the Ca21-dependent phosphatase CaMKII
(Bouvard et al., 1998), such that inhibition of CaMKII pre-
serves the high affinity state of a5b1. A link between inte-
grin signaling and CaMKII has also been demonstrated in
vascular smooth muscle (Bilato et al., 1997). Activation of
CaMKII after Ca21 influx through L-type channels could
reduce a5b1 affinity and reverse the enhancement of cur-
rent stimulated by a5b1 ligation. However, other possibili-
ties for initiating signals downstream from integrin ligation
may also exist, including pathways involving phospholi-
pase C and protein kinase C (Somogyi et al., 1994).
It is likely that avb3 and a5b1 integrins associate directly
with one of the L-type Ca21 channel subunits (e.g., a1c) or
with another protein that controls gating or modulates
channel activity. A number of cytoplasmic signaling mole-
cules are potential candidates to interact with the calcium
Figure 8. Diagram of hypothesized interactions between avb3
and  a5b1 integrins and the voltage-gated Ca21 channel in vascular
smooth muscle. See Discussion for details.Wu et al. Integrin Modulation of Ca21 Current 251
channel. Data from recent experiments on the L-type Ca21
channel in visceral smooth muscle (Hu et al., 1998) have
shown that PDGF, which activates a receptor tyrosine
kinase, enhances L-type Ca21 current and this effect is
blocked after dialysis of the cells with anti-FAK or anti-
Src antibodies. Furthermore, a1c coprecipitates with c-Src
in that tissue and has a potential tyrosine phosphorylation
site (Koch et al., 1990). Dialysis of SMCs with c-Src (Wije-
tunge and Hughes, 1995) or with a peptide that activates
c-Src (Wijetunge and Hughes, 1996) results in enhance-
ment of Ca21 current. Taken together, these results and
our own preliminary data showing that tyrosine kinase in-
hibitors reverse the enhancement of current in response to
insoluble FN (Wu, X., G.A. Meininger, G.E. Davis, J.E.
Mogford, S.H. Platts, and M.J. Davis. 1997. Microcircula-
tion. 4:136a) suggest that the pore-containing subunit of
the L-type Ca21 channel may be tyrosine phosphorylated
by c-Src, which in turn is regulated by integrin ligation.
Additional experiments will be needed to directly test this
idea.
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